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Previous studies of dendri t ic  cells (DC)1 (reviewed in 1-3) have revealed the potent  
immunos t imu la to ry  capacities of this class of leukocyte. However, relatively little is 
known of their mechanism of action. We have used a polyclonal lymphocyte  mito- 
genesis system to examine  this question. Kl inker t  et al. (4) and  Phillips et al. (5) 
showed that  T cells, modified with sodium periodate, proliferate quickly and  exten- 
sively in the presence of DC. This  assay has been used to identify two stages in 
oxidative mitogenesis. In  the first stage, viable DC induce both  the release of T cell 
growth factor, or in ter leukm 2 (IL-2) (reviewed in 6-8), and  T lymphocyte respon- 
siveness to IL-2. In  the second stage, which can occur in the absence of DC, IL-2 
alone mediates proliferat ion of these responsive T cells. 
M a t e r i a l s  a n d  M e t h o d s  
Animals. Mice were of either sex and 4-14 wk old. Swiss mice were from Taconic Farms, 
Germantown, NY, and the Laboratory Animal Research Center of The Rockefeller University; 
C3H/HeJ were from The Jackson Laboratory, Bar Harbor, ME; all other inbred strains were 
from The Trudeau Institute, Saranac Lake, NY. 
Antibodies. 33D1 (9) and B21-2 (10) are rat monoclonal antibodies specific for mouse DC 
and IA b'd antigens, respectively. The latter also binds to Swiss mouse cells. Both antibodies were 
purified by M. Witmer, The Rockefeller University, by diethylaminoethyl cellulose fractiona- 
tion of ascites. 
Primary cells. Mice were killed in chloroform vapor or by cervical dislocation. Spleen cell 
suspensions were prepared by teasing with fine forceps and pressing through a stainless steel 
mesh in RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY). For 
unfractionated spleen cells, the suspension was treated with ammonium chloride (0.88%: 
Mallinckrodt Inc., Science Products, Div., St. Louis, MO) to lyse erythrocytes. Spleen adherent 
cells, representing 1-2% of the total were obtained by culture in medium (see below) on 100- 
mm petri dishes (3002; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) for 2- 
3 h at 37°C. Nonadherent cells were then removed by rigorous washing; the adherent cells 
remaining consisted primarily of DC and macrophages in a ratio of ~ 1:3 (11). After overnight 
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culture the cells were harvested by gently pipetting over the tissue culture surface. Enriched 
populations of DC were derived from low density adherent cells that consist predominantly of 
DC and macrophages. After overnight culture, macrophages were depleted by readherence to 
60-mm petri dishes (3002; Falcon Labware). 
T lymphocytes (>90% Thy-1 positive) were obtained from mixed spleen and mesenteric 
lymph node cell suspensions passed over nylon wool columns as described (12). 
Medium for cell culture was R P M I  1640 supplemented with 2.5-10% heat-inactivated fetal 
bovine serum (KC Biologicals Inc., Lenexa, KS), 2-mercaptoethanol (5 X 10 -5 M; Sigma 
Chemical  Co., St. Louis, MO),  gentamycin sulphate (20/~g/ml; Schering Corp., Kenilworth, 
N J) and, for experiments in Table  II, indomethacin (1/~g/ml; Sigma Chemical Co.). Cells were 
irradiated with 1,500 rad from a laTCs source (Gamma Cell 1000; Atomic Energy of  Canada 
Ltd., Ottawa,  Canada). 
Oxidative Mitogenesis Assay. T cell mitogenesis was induced by modification of  cells with 
periodate (13). In one experiment (see Fig. 1) stimulators and /o r  responders were treated, but 
in all others only responder T cells were modified. T lymphocytes were washed twice in ice-cold 
phosphate-buffered saline with calcium and magnesium (Gibco Laboratories) and resuspended 
in the same to 2 × 10V/ml. An equal volume of a freshly prepared solution of sodium 
m-periodate (Sigma Chemical Co.) at 0.5 m g / m l  was added to the cells and incubated on ice 
for 15 min. Control cells were treated with buffer alone. The cells were centrifuged, without 
further dilution, at 300 g for 10 min and washed once in medium (2.5% serum) before use. 
Graded numbers of irradiated stimulators were added to 4-5 × 105 periodate-treated T cells 
in a total volume of 200 #1 in flat-bottomed microtiter plates (3596; Costar, Data Packaging, 
Cambridge,  MA). At 24-27 h, 0.5/~Ci/well  of [3H]thymidine (Schwarz/Mann Div., Becton, 
Dickinson & Co., Orangeburg,  NY) was added and cells were harvested 14-18 h later on a 
multisample harvester. Kinetic studies (not shown) demonstrated that irrespective of stimulator 
dose, the bulk of DNA synthesis occurred from ~24 h onwards. Unless otherwise stated, results 
are given as the means of  triplicate cultures; standard deviations were generally <15% of the 
mean. 
Primary Mixed Leukocyte Reaction. Graded doses of irradiated unfractionated spleen or spleen 
adherent cells were used to stimulate proliferation of allogeneic T lymphocytes in microtiter 
wells as described (11). 
Cytotoxic Elimination of Accessory Cells in Oxidative Mitogenesis. Accessory cells were eliminated 
by treatment with monoclonal anti-Ia or anti-DC antibody and complement,  in two different 
types of experiment. Medium for treatment contained 2.5% serum throughout. 
T R E A T M E N T  OF STIMULATORS BEFORE ADDITION TO T CELLS (SEE TABLES I, II) .  DC were 
eliminated from fresh spleen adherent cells by treatment with antibody and complement during 
the adherence step as described (11). Cultured adherent and unfractionated spleen cells were 
resuspended at 5-10 X 106/ml. They were incubated on ice with an equal volume of 33D1 or 
B21-2 antibody for 5-45 min at final, saturating concentrations of 10/~g/ml. Another volume 
of complement was added and the mixture was incubated at 37°C for 45-55 min. The  
complement source was rabbit serum screened for low background toxicity, lyophilized, and 
stored at - 7 0 ° C  before use at a final dilution of 1:16. After treatment the cells were washed 
two to three times in ice-cold RPMI,  irradiated, and used as stimulators for T cell oxidative 
mitogenesis. 
T R E A T M E N T  OF MIXED POPULATIONS TO EXAMINE DC-MEDIATED T CELL ACTIVATION (SEE TABLES 
nI-v  AND FinS. 2, 3). Unirradiated DC were mixed with periodate-modified T cells at ratios of 
1:100 to 1:30 as indicated. The  mixture was either treated immediately (t = 0) or distributed 
into 16-mm wells (3524; Costar) at 107/well in 1 ml of medium. At subsequent times, cells were 
harvested and the culture supernatant was saved. Treatment  with antibody and complement 
was as described above except that the initial cell density was 10-12 × 107/ml and the cells 
were not irradiated. After washing, the mixture was distributed into microculture plates at 
2-5 × 105/well and 200 ~l total volume. The  cultures were maintained in fresh medium, culture 
supernatant at 50%, crude rat IL-2 at 2.5-5%, purified mouse IL-2 at ~ 10 -9 M, or supplemented 
with DC at 1 × 104/well. 
Interleukin Assays. Two assays (modifications of those in refs. 14 and 15, respectively) were 
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THYMOCYTE ~aITOCENESIS. C3H/HeJ  thymocytes were plated at 4-5 × 105/well in flat- 
bottomed microtiter wells in a total volume of 100/~1. Medium contained 2.5% serum, 0.8 #g/  
ml phytohemagglutinin (Burroughs Welleome, Greenville, NC), a concentration determined to 
be suboptimal to induce mitogenesis alone, and 5 × 10 -5 M 2-mercaptoethanol, which is 
essential for optimal responses to IL-1. Proliferation was assessed in a 14-18 h [SH]thymidine 
pulse from day 2-3. 
PROLIFERATION OF AN 1L-2-DEPENDENT CELL LINE, A cytotoxic T lymphocyte line (CTLL) 
was used which proliferates in response to IL-2 but not to IL-1 (16). Two clones, CTLL-A2 and 
CTLL-A11, were used interchangeably. The line was maintained in minimal essential medium, 
Eagle (Gibco Laboratories) supplemented with 10% serum, 5 X 10 -5 M 2-mercaptoethanol, 5 
/,tg/ml glutamine, minimal essential medium amino acids (Gibco Laboratories), and 4-5% 
polyclone (Collaborative Research Inc., Lexington, MA) as a source of IL-2. It was passaged 
after harvesting with 0.5% EDTA (Mallinckrodt Inc.). On the day of assay, growth medium 
was replaced with IL-2-free medium at least twice over 4-5 h. After harvesting and washing to 
remove EDTA, cells were plated at 5-10 X 10S/well in flat-bottomed wells. Serial dilutions of 
sample were added to a total volume of 100 /~1. Proliferation was assessed in a 
[SH]thymidine pulse from day 1-2. 
IL-2. IL-2 was obtained from three sources. Supernatants from oxidative mitogenesis 
cultures that were found to contain IL-2 (see Results) were stored at --20°C before use. A 
standard source of crude rat IL-2 was prepared and generously provided by W. van Voorhis, 
The Rockefeller University. This was derived from Sephadex G 150 fractionation of a serum- 
free, concanavalin A (Con A)-stimulated spleen cell supernatant; fractions in the 14,000-28,000 
mol wt range, which supported proliferation of Con A blasts, were pooled. Purified mouse 
IL-2 was prepared as described (I7). Activity migrated as a single band of 23,000 tool wt by 
polyacrylamide gel electrophoresis and a single peak of isoelectric point (pI) 4.0-4.1 by 
isoelectric focusing. The concentration of IL-2 used in studies on T cell activation was saturating 
in the CTLL assay. 
Results 
The DC is the Critical Accessory Cell for T Lymphocyte Proliferation in Oxidative Mitogene- 
sis. T o  s tudy  the  mechan i sm of  ac t ion  o f  DC,  we chose a polyc lonal  mitogenesis  
system in which  T cells prol i fera te  af ter  t r ea tmen t  wi th  sodium per iodate .  In i t ia l  
s tudies conf i rmed  the work o f  Kl inker t  et al. (4) showing tha t  DC were po ten t  
s t imula tors  o f  ox ida t ive  mitogenesis  (Fig. 1). Per ioda te  t r ea tmen t  o f  DC,  T cells, or 
bo th ,  lead  to large T cell prol i fera t ive  responses tha t  were 10-100 t imes greater  t han  
those of  unmod i f i ed  cells. I r r a d i a t e d  (1,500 rad)  and  un i r r a d i a t e d  DC had  s imi lar  
effects (not shown). O n  a per  cell basis, enr iched  DC (>90% pure)  were at  least 100 
t imes  more  act ive as accessory cells t han  unf rac t iona ted  spleen cells, which con ta ined  
<1% DC (Fig. 1). 
To  documen t  the  con t r ibu t ion  o f  DC further,  selective deple t ion  exper iments  were 
pe r fo rmed  using the  specific an t i -D C monoc lona l  an t ibody ,  33D1. T r e a t m e n t  wi th  
33D1 and  c o m p l e m e n t  removed  90% or  more  o f  the  T cell s t imula to ry  capac i ty  o f  
spleen adhe ren t  cells. These  were tested immed ia t e ly  af ter  isolat ion from the an ima l  
(Table  I) or  fol lowing overnight  cu l ture  (Table  II). A n t i -D C an t ibody  and  comple-  
men t  also removed  50-75% of  the  s t imula to ry  capac i ty  of  freshly p repared ,  unfrac-  
t i ona t ed  spleen cells (Table  II).  T h e  effects o f  33D1 and  complemen t  were s imi lar  to 
those p r o d u c e d  by  specific an t i - I a  a n t i b o d y  a n d  c omple me n t  (e.g., T a b l e  I, exper iment  
2). Select ive e l imina t ion  o f  D C  had  s imi lar  effects on accessory funct ion in oxida t ive  
mitogenesis  and  the p r i m a r y  mixed  leukocyte  react ion ( M L R )  (Tab le  II  and  ref. 11). 
T r e a t m e n t  wi th  33D1 a n t i b o d y  alone,  an t ibody ,  and  hea t - inac t iva ted  complemen t  
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F1o. l. The  relat ive potency of  DC compared  wi th  unf rac t iona ted  spleen cells as s t imula tors  in 
oxida t ive  mitogenesis.  Graded  number s  of i r rad ia ted  Swiss mouse  DC ( ) or unf rac t iona ted  
spleen cells (-  - -) were added  to 5 × l0  s T cells in m e d i u m  con ta in ing  5% serum, and  prol i ferat ion 
was assessed. Per iodat ion  was carr ied out  before mixing,  on both  s t imula tors  and  responders (O), 
responders  only  (~), s t imula tors  only (Lx), or nei ther  (×). 
not alter DC function. We conclude that the DC is the critical cell required to 
stimulate the proliferation of periodate-modified T cells. 
Release of Interleukins during Oxidative Mitogenesis. Interleukins, notably IL-1 (lym- 
phocyte-activating factor, reviewed in 19) and IL-2 (T cell growth factor, reviewed in 
6-8), can act as effector molecules for lymphocyte mitogenesis. We therefore tested 
supernatants from DC, T cells, and DC-T cell co-cultures for interleukin activity in 
two standard bioassays. These were costimulation with phytohemagglutinin of thy- 
mocyte mitogenesis, which detects both IL-1 and IL-2 (18), and proliferation of an 
IL-2-dependent T cell line, which detects only IL-2. 
The  supernatants from DC-T cell co-cultures were active in stimulating both 
thymocyte mitogenesis and proliferation of the IL-2-dependent C T L L  line (Fig. 2). 
The  interleukin activity in both bioassays was parallel. Interleukins were not detected 
in cultures of DC alone (up to 106/ml; not shown). Low levels of IL-2 activity were 
found in supernatants of T cells cultured in the absence of DC, but these were always 
<10% of that of the DC-T cell mixture. During oxidative mitogenesis (DC plus 
periodate-modified T cells), IL-2 activity was detected at the first time point studied 
(3 h), peaked by 20 h, and then fell rapidly in the 2nd d of culture (Fig. 2). Similar 
kinetics were observed in four consecutive experiments. If  the T cells were not 
periodate-modified (the syngeneic MLR),  the rate of IL-2 release was slower, but 
proceeded continuously over 4 d in culture (Fig. 2). We conclude that DC stimulate 
the release of IL-2 during DC-T cell co-culture. The bioassays did not allow us to 
determine whether IL-1 was also present. 
The Dendritic Cell Induces Periodate-Modified T Cells to Respond to Soluble Factors Released 
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TABLE I 
Selective Ehmination of DC Reduces the Accessory Activity of Freshly Prepared 
Spleen Adherent Cells 
~'.n i _xver - Strain Treatment Proliferation 
ment 
cprtl 
1 C × B6 FI O 66,123 
O/C * 53,199 
33D1 62,177 
33D t/C* 7,802 
2 C × B6 F1 O/heat 56,484 
33D 1/heat 52,856 
B21-2/heat 51,140 
O/C* 44,024 
33D l/C* 6,339 
B21-2/C* 1,486 
3 D2 × C F1 O/C* 47,067 
33D l/C* 4,535 
4 D2 × C F1 O/C* 33,226 
33D l/C* 1,288 
5 B 10.TL O/C* 52,206 
33D 1/C* 4,059 
Freshly harvested, unfractionated spleen cells from the mouse strains indicated 
were irradiated and cultured at 3-4 × l0 s per 16-mm well in the presence 
(33D1; B21-2) or absence (O) of antibody and complement (C*, fresh; heat, 
heated at 56°C for 30 min; no symbol, medium only at this stage), as indicated 
for 60 rain at 37°C. Nonadherent cells were removed by washing, thus 
providing adherent spleen cells at doses estimated to be 5-10 × 104 per well. 
20-30% of the adherent cells were DC. Periodate-modified T ceils were added 
as responders in 2.5% serum. Proliferation was measured on the second day of 
culture and the responses of T cells only were subtracted. 
1105 
cultures conta ined  IL-2 activity, these supernatants  alone would not induce prolifer- 
a t ion o f  per iodate-modif ied  T cells (see below for examples). We therefore designed 
exper iments  to test if  T cells became  responsive to growth factors after co-culture with 
DC. D C  and T cells were cul tured for varying lengths of  t ime (0-20 h), after which 
the DC were killed with  an t i -DC or ant i - Ia  monoclonal  an t ibody  and complement .  
Remova l  of  DC with ei ther of  the ant ibodies reduced the subsequent  prol iferat ive 
response of  the t reated cells, recul tured in fresh medium.  However ,  ant i - Ia  was more 
effective than  an t i -DC at later t imes (10-20 h, Tab le  III). Prol iferat ion o f  DC-deple ted  
cultures was restored by add ing  back small numbers  (1-3%) of  DC,  showing that  
t r ea tment  wi th  an t ibody and complemen t  had  not al tered the T cells (Table III). 
T h e  striking f inding was that  T cells that  had been cul tured with DC became 
progressively responsive to soluble factors (Table  III and Fig. 3). T h e  lat ter  were 
ob ta ined  from the D C - T  cel l -condit ioned medium,  or from a s tandard  interleukin 
source (crude rat IL-2 der ived from Con  A-s t imula ted  rat spleen cells). Responsiveness 
to soluble factors increased progressively with t ime (Table  III and Fig. 3), and with 
increasing numbers  of  DC (Fig. 3), but  T cells cul tured in the absence of  DC were not 
responsive (Fig. 3). We  conclude that  at least two events occur in the 1st d of  an 







niversity user on 15 July 2020
1 106 TWO STAGES IN DENDRITIC CELL-INITIATED T PROLIFERATION 
TABLE II 
Selective Elimination of DC Reduces Accessory Cell Function of Cultured Spleen Adherent Cells and Fresh 
Unfractionated Spleen Cells 
Proliferative response of 5 × 105 responders to stim- 
Stimulators Treatment ulators at a dose of (×10 -3) 
Oxidative mitogenesis 
Spleen adherent cells 
Unfractionated spleen cells 
Allogeneic MLR 
Spleen adherent cells 
Unfractionated spleen cells 
cpm 
24 12 6 3 
O 49,010 28,710 15,050 7,150 
O/C* 40,765 23,752 18,238 7,505 
33D1 38,689 30,324 18,887 8,903 
33D1/C* 8,765 4,685 1,782 664 
320 160 80 40 
O 11,147 9,269 5,220 3,186 
O/C* 19,461 10,280 5,871 3,657 
33D1 25,046 13,864 7,728 3,796 
33D1/C* 8,071 3,194 1,687 713 
24 12 6 3 
O 87,524 61,697 44,347 24,724 
O/C* 76,766 60,498 45,453 19,375 
33D 1 75,995 53,513 31,249 12,686 
33D 1/C * 2,707 1,150 790 523 
320 160 80 40 
O 60,739 30,880 12,763 2,079 
O/C* 37,464 20,264 6,211 2,052 
33D 1 63,943 41,976 17,254 6,544 
33D1/C* 14,874 3,064 655 355 
C × B6 Fa stimulator cells were treated in the presence or absence of antibody and complement (designated 
as in Table I). The stimulators were irradiated and added to C × B6 F1 periodate-treated T cells (oxidative 
mitogenesis) or untreated BALB/c T cells (allogeneic MLR). Oxidative mitogenesis was assayed from day 
1-2: control responses with unmodified T cells were <700 cpm. The allogeneic MLR was assayed from day 
4-5: syngeneic MLR responses were <2,250 cpm. Cultures were a 2.5% serum. The proportion of DC, 
macrophages and Ia-bearing (Ia +) cells was determined by indirect immunofluorescence using specific 
monoclonal antibodies 33D1, F4/80 (38), and B21-2, respectively. Spleen adherent cells were the same 
population characterized previously (ref. 11). They contained a two- to threefold excess of Ia ÷ macrophages 
to Ia + DC. Unfractionated spleen cells contained <1% DC, 3% macrophages, and 65% Ia + cells. Killing 
with 33D1 and complement was ~25% in spleen adherent cells but was not detectable in unfractionated 
spleen cells. 
to  s o l u b l e  fac tors ,  a n d  D C  i n d u c e  re lease  o f  t h e  r e q u i r e d  fac to rs  i n to  t h e  c u l t u r e  
m e d i u m .  
Purified IL-2 Drives Proliferation of Responsive T Cells. T o  p i n p o i n t  t h e  m o l e c u l e  
r e s p o n s i b l e  for  m i t o g e n e s i s ,  we  t e s t e d  a p u r i f i e d  p r e p a r a t i o n  o f  m o u s e  IL-2 ,  p r e p a r e d  
as p r e v i o u s l y  d e s c r i b e d  f r o m  t h e  s u p e r n a t a n t s  o f  C o n  A - s t i m u l a t e d  sp leen  cells (17). 
T h i s  IL-2  h a d  a n  a p p a r e n t  m o l e c u l a r  w e i g h t  o f  23,000,  m i g r a t e d  as a s ing le  b a n d  o n  
i soe lec t r ic  f o c u s i n g  w i t h  a p I  o f  4 .0 -4 .1 ,  a n d  s a t u r a t e d  t h e  IL-2  b i o a s s a y  a t  10 -9 M.  
A f t e r  v a r y i n g  t i m e s  o f  D C - T  cell  c o - c u l t u r e ,  D C  w e r e  r e m o v e d  w i t h  a n t i - I a  
a n t i b o d y  a n d  c o m p l e m e n t .  T h e n  t h e  T cells were  r e c u l t u r e d  in  f resh m e d i u m ,  t h e  
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HOURS OF CULTURE 
Fro. 2. Kinetics of  interleukin production during De- induced T lymphocyte proliferation. The  
responses examined were oxidative mitogenesis (O) and the syngeneic M L R  ([3). Swiss mouse DC 
were mixed with periodate-modified (O, O) or untreated ~lg, El) T cells at a ratio of 1:50 in medium 
containing 2.5% serum. Closed symbols indicate T cells cultured in the absence of DC. The  mixture 
was distributed at 8 x 10 ~ per well in I ml into 16-mm wells. Cells from individual wells were 
harvested at the times shown. The  supernatant  was assayed for interleukin activity by determining 
the induction of thymocyte mitogenesis (left) and proliferation of an IL-2-dependent T cell line 
(right). 
2, tested at 10 -9 M, had similar activity to the DC-T cell conditioned medium in 
promoting proliferation (Table IV), which was likewise restored by crude rat IL-2 or 
small numbers of DC (not shown). Fresh T cells, or T cells cultured in the absence of 
DC, did not respond to IL-2. Unmodified T cells (1 d syngeneic MLR) also became 
responsive to IL-2 when cultured with DC, but the responsiveness was <20% of that 
seen in oxidative mitogenesis (Table IV, experiment 2). We conclude that IL-2 itself 
mediates the proliferation of DC-stimulated T cells. 
IL-2 and Viable DC Do Not Act Synergistically. IL-2 replaces DC after an initial 
period (6-20 h) of  DC-T cell co-culture. We asked whether IL-2 could enhance the 
function of live DC when both were present continuously from the onset of  culture. 
Purified IL-2, used at a concentration that saturated the IL-2 bioassay, and mediated 
the proliferation of activated T cells, did not enhance oxidative mitogenesis 
induced by a wide range of  DC doses (Table V). This is in agreement with the results 
of  experiments in Table  IV where purified IL-2 did not enhance proliferation of cells 
treated with complement alone. We conclude that IL-2 mediates proliferation of DC- 
activated T cells but does not act synergistically with live DC in the activation step. 
As a corollary, the restoration of proliferation in activated T cells is not due to a 
synergistic effect of IL-2 with very small numbers of residual DC. 
Discussion 
The DC is the Principal AccessoTy Cell in Oxidative Mitogenesis. Novogrodsky and 
Katchalski (20) discovered that lymphocytes proliferated after treatment with sodium 
periodate, or with neuraminidase and galactose oxidase. Greineder and Rosenthal 
(21) noted that oxidative mitogenesis in the guinea pig, like other T cell responses, 
required accessory cells. Either the accessory cells, assumed to be macrophages, or the 
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TABLE I l i A  
DC Progressively Activate T Cells to Respond to Soluble Factors Released into 
the Culture Supernatant 
Co-cuhure of DC 
with periodate T cells 
Proliferative response of 3 X l0 s treated cells 
after reconstitution with: 
T ime Trea tment  Medium DC Superna- Crude rat 
t am IL-2 
h cpm 
0 O 32,107 46,864 30,598 
O / C *  18,978 69,200 22,239 
33D1/C* 407 48,663 1,761 
B21-2/C* 46 37,835 393 
10 
20 
O 28,983 48,633 28,420 38,194 
O / C *  24,365 68,779 24,114 31,159 
33D1/C* 698 45,334 1,706 7,669 
B21-2/C* 106 33,683 349 3,424 
0 46,800 66,809 57,801 55,107 
O / C *  40,t03 79,038 58,125 62,245 
33D1/C* 4,117 73,804 28,903 37,864 
B21-2/C* 340 64,094 12,879 23,041 
O 68,411 80,622 63,337 81,827 
O / C *  57,165 94,790 76,165 78,137 
33D1/C* 15,128 77,545 53,536 60,292 
B21-2/C* 1,487 83,974 47,032 58,895 
O 59,939 113,962 98,781 92,952 
O / C *  50,422 84,596 91,731 66,807 
33D1/C* 25,493 56,655 70,082 46,724 
B21-2/C* 16,858 63,742 90,504 61,654 
At successive times, mixtures of Swiss mouse DC and periodate-modified T 
cells at a ratio of 1:100 were treated with antibody and complement as 
indicated. They  were then recultured in fresh medium containing 2.5% serum, 
fresh DC at 3% of the total, a saturating (2.5% vol/vol) concentration of crude 
rat IL-2 (used to obtain an estimate of the max imum response attainable at 
each time after removal of DC), or 50% of the culture supernatant  collected at 
each time point. This contained progressively increased concentrations of IL- 
2 in a C T L L  assay as shown below. Rat  IL-2 was diluted to a 10% starting 
concentration and the background was 1,122 cpm. 
IIIB 
Time of su- 
pernatant  col- 
lection 
Proliferative response of C T L L  cells with supernatant  
at concentration of: 
50% 25% 12% 6% 
a ~pm 
3 6,424 3,708 2,673 1,536 
6 39,283 28,340 17,739 9,668 
10 47,859 40,881 33,536 18,831 
20 42,128 38,433 38,799 26,470 
rat IL-2 48,244 44,058 37,103 ND* 
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FIG. 3. DC activate T lymphocytes to become responsive to soluble factors. The experiment 
illustrated is similar to that in Table Ill, except that I l- and 17-h points were examined, two ratios 
of DC:T were used, and the medium contained 10% serum. Briefly, at the times indicated, the cells 
were treated with B21-2 and complement (aIa/C) or complement alone (O/C). They were 
recultured in fresh medium (m), or 50% supernatant  (s) from the original 11- or 17-h cultures. 
Cultures in medium with 2.5% serum were also tested with quali tatively similar results. However 
the degree of proliferation was reduced when the cells were cultured in 2.5% serum before treatment 
(the activation step) but the serum concentration had no effect after activation (results not shown). 
1109 
that enriched populations of DC were active accessory cells in the rat, and that 
macrophages and lymphocytes were in fact weak or inactive. Philips et al. (5) and 
van Voorhis et al. (22) found similarly in mouse and humans, respectively. We 
confirmed in this paper that highly enriched (>90% pure) mouse spleen DC were 
potent stimulators of oxidative mitogenesis (Fig. 1). Furthermore, selective elimination 
of DC with the specific 33D1 monoclonal antibody and complement, markedly 
reduced the accessory function of unfractionated spleen and spleen adherent cells 
(Tables I and II). This specific, negative selection approach, which was applied to 
fresh or cultured cell suspensions, extends previous evidence that the DC is the 
principal leukocyte mediating oxidative mitogenesis. 33D1 is the first cell-specific 
antibody to so strikingly diminish accessory function. 
Oxidative Mitogenesis as a Model for a De-mediated T Cell Response. Oxidative mito- 
genesis is a particularly useful model to study the mechanism of action of De .  First 
the response is large, comparable in magnitude to lectin-stimulated proliferation. 
Second, unlike lectin models, it is easy to make T cells accessory cell dependent: a 
single passage of spleen or lymph node cells over nylon wool reproducibly yields T 
cells that are dependent upon small numbers of De.  Third, responses are rapid so 
that within 2 d it is possible to monitor early events in moving the T cell from a 
resting or unprimed state into its first cell cycle. Responses to specific antigens, such 
as alloantigens in the primary MLR, or to soluble protein antigens, require long assay 
times and/or  primed T cells. Fourth, oxidative mitogenesis is blocked by anti-Ia 
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TABLE IV 
Purified IL-2 Mediates the Proliferation of T Lymphocytes after Their Activation by DC 
Experiment/Assay 
Co-culture 
Proliferative response of 3 × l0 s treated 
cells recultured in: 
~ n 





0 O/C* 59,452 53,678 47,556 
B21-2/C* 65 1,097 507 
6 O/C* 129,158 1 3 6 , 8 1 2  105,801 
B21-2/C * 719 18,395 12,450 
10 O/C* 81,667 84,366 82,395 
B21-2/C* 3,426 46,407 29,968 
20 O/C* 136,451 1 3 6 , 7 1 5  133,023 
B21-2/C* 46,446 1 2 7 , 6 0 8  102,386 
Experiment 2 
Oxidative mitogenesis 
1-d syngeneic MLR 
Periodate T cells only 
0 O/C* 99,707 83,846 79,049 
B21-2/C* 86 232 617 
15 O/C* 120,906 1 5 4 , 5 9 4  125,406 
B21-2/C* 32,982 1 1 6 , 6 3 3  112,995 
0 O/C* 3,463 3,659 3,139 
B21-2 67 577 289 
15 O/C* 17,308 17,067 16,975 
B21-2/C* 4,832 12,521 11,751 
0 O/C* 141 145 105 
B21-2/C* 83 7I 1 I29 
15 O/C* 905 3,618 1,500 
B21-2/C* 149 871 528 
As in Table III and Fig. 3, cells were cultured for varying lengths of time before treatment with or without 
anti-la antibody and complement. They were then recultured in either fresh medium containing 2.5% or 
10% serum (experiments I and 2, respectively) or the same supplemented with a saturating concentration 
of purified mouse IL-2, or DC-T cell culture supernatant. In experiment 1, the supernatant added at t = 
0 was from a 20-h culture of DC and periodate-modified T cells; those at later times were from the original 
cultures. In experiment 2, the supernatant used throughout was from a similar 18-h oxidative mitogenesis 
culture. Addition of small numbers of purified DC restored the proliferation of B21-2/C*-treated cultures 
and the effect of crude rat IL-2 was similar to that of pure mouse IL-2 (results not shown). In experiment 
2, where pure IL-2 was added at 15 h, T cells were exposed to IL-2 for i2 h before the thyrnidine pulse. In 
other experiments, incubation was continued for 28 h before pulsing. The results were similar to those 
shown here. Cultures of DC with unmodified T cells are termed 1-d syngeneic MLR. 
ously,  i n d i c a t i n g  t h a t  po lyc lona l  a c t i v a t i o n  w i t h  p e r i o d a t e  r equ i r e s  m a j o r  h i s t o c o m -  
p a t i b i l i t y  c o m p l e x  ( M H C )  a n t i g e n s  as do  m a n y  a n t i g e n - i n d u c e d  p ro l i f e r a t ive  re- 
sponses .  
T h e  prec i se  m e c h a n i s m  w h e r e b y  p e r i o d a t e  e n h a n c e s  T cell m i t o g e n e s i s  is c u r r e n t l y  
u n k n o w n .  Poss ib ly  p e r i o d a t e  s i mp l y  e n h a n c e s  t he  so-ca l led  syngene i c  M L R  t h a t  
occurs  w h e n  D C  a n d  T cells a re  m i x e d  (24). All  t he  even t s  t h a t  o c c u r  w h e n  D C  are  
a d d e d  to  p e r i o d a t e - m o d i f i e d  T cells a re  q u a n t i t a t i v e l y  i nc reased  re la t ive  to even t s  
o c c u r r i n g  in the  s y n g e n e i c  M L R  (T ab l e  IV,  e x p e r i m e n t  2; a n d  Fig. 2). 
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TABLE V 
Purified IL-2 Does Not Enhance the Effect of DC m Oxidative 
Number of DC 






2 × 104 90,895 82,803 
I X 104 46,045 46,138 
5 × 10 a 27,788 23,058 
2.5 × 10 a 10,133 9,803 
1.2 × t0 s 3,405 4,485 
6 × l02 1,747 2,328 
3 × 102 805 1,480 
None 350 1,068 
Proliferative response of 4 X 105 
unmodified T cells 
2 X 104 3,573 6,393 
1 × 104 2,007 2,417 
5 × 10 a 837 1,760 
None 88 538 
Graded numbers of irradiated Swiss mouse DC were added to periodate- 
treated or unmodified T cells. The proliferative response was assessed in 
medium containing 10% serum or the same supplemented with a saturating 
concentration of pure mouse IL-2 (as used for experiments in Table IV). 
1111 
p rov ided  a two-stage mode l  o f  DC- in i t i a t ed  mitogenesis.  In  the  first stage, v iable  DC 
induce  bo th  the  release of  IL-2 a n d  T lymphocy te  responsiveness to this factor. In  the  
second, which  does not  require  v iable  DC,  T cells prol i fera te  in response to the  IL-2 
tha t  is genera ted  in the  cu l tu re  med ium.  
Release o f  IL-2 ac t iv i ty  into the  cu l tu re  me d ium,  and  acquis i t ion of  responsiveness 
to IL-2,  occurred over  a s imi lar  t ime course (compare  Fig. 2 and  T a b l e  III).  Both 
events were induced  by  DC and  were requi red  for mitogenesis.  I t  is l ikely tha t  the 
IL-2 was der ived  from T cells, ra ther  than  DC,  since T cell lines are  the only 
homogeneous  popu la t ions  known to release this factor (e.g., 25, 26). W e  do not  know 
if  the  s u b p o p u l a t i o n  of  T cells tha t  responds to IL-2 is different  from, or  overlaps,  tha t  
which  releases IL-2. IL-2 itself, in the  form of  supe rna t an t  from D C - T  cell cocultures,  
or  as c rude  or  pu re  p repa ra t ions  from Con A-s t imu la t ed  spleen cells, had  no effect on 
T cells tha t  were not  first ac t iva ted  by  DC. 
Previous work  ind ica t ed  tha t  T cell growth  factor, or IL-2,  does not  t r igger  the 
growth  of  rest ing T cells (27, 28). Ra the r ,  IL-2 acts in conjunc t ion  wi th  o ther  signals, 
or  these cells must  first be  " a c t i v a t e d "  to respond  to IL-2,  a process which includes 
expression o f  funct ional  receptors  (28-30). T h e  dis t inct ive  f indings in this paper ,  
which were verified with  a h ighly  pur i f ied  p repa ra t ion  o f lL -2 ,  were: (a) responsiveness 
to IL-2 was acqu i red  progressively (6-20 h) du r ing  exposure  to small  numbers  of  DC,  
before the  onset of  the  first cell cycle; (b) sufficient IL-2 was genera ted  in D C - T  cell 
co-cul tures to account  for the  prol i fera t ive  response; and  (c) IL-2 seems to be the  only  
m e d i a t o r  r equ i red  by  the ac t iva t ed  T cell to ensure its first cell division. 
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in which T cells were cultured with DC for varying lengths of time. The DC were 
then killed with anti-Ia or anti-DC antibody and complement. Such treatment 
drastically inhibited subsequent proliferation in fresh medium. The greater efficacy 
of anti-Ia antibody, compared with 33D1 at later times was presumably due to more 
efficient killing of DC by the former: the 33D1 antigen may be modulated, become 
inaccessible, or other factors could be involved. Anti-Ia also became less efficient at 
the later times studied (15-20 h). Possibly the T cells become committed to replication 
in the absence of DC and exogenous IL-2. Finally, in these experiments, mitogenesis 
was triggered by soluble factors, including a highly purified preparation of IL-2. The 
latter does not seem to enhance the function of DC (Tables III,  IV, and V, and Fig. 
3). Rather,  the DC triggers the T cell to release and to respond to IL-2: the number  
of DC in the culture tightly controls the extent of lymphocyte activation, and 
endogenous IL-2 release and action. 
It is important  to relate oxidative mitogenesis to other T lymphocyte responses. 
Primed cytolytic T cells may be stimulated by antigen acting in concert with soluble 
factors, and may not require interaction with intact accessory cells (31). Some lectins 
and other stimuli (27, 32-35) induce IL-2 responsiveness, again in the apparent 
absence of accessory cells. For example, Larsson and co-workers (34, 35) studied T 
cells depleted of Ia-bearing cells. Culture with Con A altered the T cell in a few hours 
so that it then responded to exogenous factors from Con A-stimulated spleen cell 
supernatants. In contrast, DC-depleted, periodate-modified T lymphocytes proliferate 
little if at all in the presence of IL-2. Ia-bearing cells are required for Con A 
mitogenesis (36, 37), and it has been suggested that such cells function solely to induce 
IL-2 release. In oxidative mitogenesis, the Ia-bearing DC itself alters the T cell to 
respond to IL-2, in addition to inducing IL-2 release. Conceivably Con A mimics the 
action of DC in inducing T cell responsiveness. Because the first stage in oxidative 
mitogenesis demands cellular interaction with live DC, and because sufficient IL-2 is 
produced to drive the second, proliferative stage, this model may approximate more 
closely to the physiological triggering of T cells. We are currently examining the 
extension of this model to antigen-driven T cell responses. 
S u m m a r y  
T cells oxidized with sodium periodate proliferate polyclonally in response to 
accessory cells. We confirmed previous work showing that DC are potent stimulators 
of this response. In addition, the accessory function of unfractionated mouse spleen 
and spleen adherent cells was markedly reduced after elimination of DC with a 
specific monoclonal antibody and complement. Therefore oxidative mitogenesis was 
used as a model to study the mechanism by which DC stimulate T cell proliferative 
responses. 
A two-stage mechanism was identified. The first stage occurred during the first 20 
h of culture, required live DC, and involved the progressive release of interleukin 2 
(IL-2) into the medium and acquisition of responsiveness to this growth factor. The 
second stage occurred between 20 and 40 h, did not require live DC, and involved 
DNA synthesis in response to IL-2. Similar events occurred during culture of DC with 
unmodified T cells (syngeneic MLR) but were quantitatively reduced. The experi- 
mental approach was to co-culture DC and T cells for up to 20 h and then kill the 
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e ra t ion  was inh ib i ted  if  the  T cells were cu l tu red  in fresh med ium.  However ,  
p ro l i fe ra t ion  was res tored when the lyrnphocytes  were cu l tu red  in the  or iginal  D C - T  
cell m e d i u m ,  or  wi th  a c rude  or  a pur i f ied p r e p a r a t i o n  of  IL-2. IL-2 d id  not  induce  
the  pro l i fe ra t ion  of  T cells tha t  had  been cu l tu red  in the  absence of  DC,  and  d id  not  
synergize wi th  v iable  DC. W e  conc lude  tha t  DC induce  prol i fera t ion  by  t ight ly  
coord ina t ing  the release of, a n d  responsiveness to, T cell growth  factor or IL-2. 
The authors are grateful to Dr. Zanvil Cohn for reviewing the manuscript. 
Received for publication 15 December 1983. 
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